Skip to main content
Clinical Trials/CTRI/2018/02/011722
CTRI/2018/02/011722
Recruiting
未知

An open label randomized study to evaluate effectiveness of indomethacin in Tuberculous Meningitis

Dr Ravi Uniyal0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: null- Tuberculous Meningitis
Sponsor
Dr Ravi Uniyal
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Ravi Uniyal

Eligibility Criteria

Inclusion Criteria

  • All Newly diagnosed cases of Tuberculos meningitis fulfilling consensus diagnostic criteria of TBM proposed by Marais et al (Lancet infect Dis 2010;10:803\-12\)

Exclusion Criteria

  • 1\.Patients already taking anti\- tubercular drugs or steroids.
  • 2\.Patients with renal dysfunction (creatinine more than 1\.5 mg/dl)
  • 3\.Human immunodeficiency virus disease
  • 4\.Patients/ attendants refusing consent

Outcomes

Primary Outcomes

Not specified

Similar Trials